0001179110-20-004530.txt : 20200402 0001179110-20-004530.hdr.sgml : 20200402 20200402171747 ACCESSION NUMBER: 0001179110-20-004530 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200402 DATE AS OF CHANGE: 20200402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOTT DARCY G CENTRAL INDEX KEY: 0001179972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 20770190 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY, INC. CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHEQUITY INC DATE OF NAME CHANGE: 20080227 4 1 edgar.xml FORM 4 - X0306 4 2020-03-31 0 0001428336 HEALTHEQUITY, INC. HQY 0001179972 MOTT DARCY G C/O HEALTHEQUITY, INC. 15 W. SCENIC POINTE DR., STE. 100 DRAPER UT 84020 0 1 0 0 Executive VP and CFO Common Stock 2020-03-31 4 A 0 7921 0 A 37921 D Common Stock 2020-03-31 4 A 0 3623 0 A 41544 D Common Stock 2020-03-31 4 A 0 19073 0 A 60617 D Common Stock 2020-03-31 4 A 0 8236 0 A 68853 D Stock Option (right to buy) 41.28 2027-03-27 Common Stock 19897 19897 D Stock Option (right to buy) 25.39 2025-03-26 Common Stock 25000 25000 D Stock Option (right to buy) 14 2024-07-30 Common Stock 100000 100000 D Stock Option (right to buy) 61.72 2028-03-27 Common Stock 14228 14228 D Stock Option (right to buy) 73.61 2029-03-26 Common Stock 15337 15337 D Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 7,921 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2022. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 3,623 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2023. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 19,073 shares on March 31, 2020. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in four equal installments of 2,059 shares on each of March 31, 2021, 2022, 2023, and 2024. The option is exercisable as to 14,922 shares. The option vests as to 4,975 shares on March 27, 2021. The option is immediately exercisable. The option is exercisable as to 7,114 shares. The remaining options vest in two equal installments of 3,557 shares on March 27, 2021, and 2022. The option is exercisable as to 3,835 shares. The remaining options vest as to 3,834 shares on each of March 27, 2021, 2022 and 2023. /s/ Darcy G. Mott 2020-04-02